Click here to sign in with

or

Forget Password?

Learn more

September 7, 2020

by Max Delbrück Center for Molecular Medicine

Hundreds of innovators, research pioneers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare. In two publications—a perspective article in the journal Nature and the LifeTime Strategic Research Agenda—they now present a detailed roadmap of how to leverage the latest scientific breakthroughs and technologies over the next decade to track, understand and treat human cells throughout an individual’s lifetime.

The LifeTime initiative, co-coordinated by the Max Delbrueck Center of Molecular Medicine in the Helmholtz Association (MDC) in Berlin and the Institut Curie in Paris, has developed a strategy to advance personalized treatment for five major disease classes: cancer, neurological, infectious, chronic inflammatory and cardiovascular diseases. The aim is a new age of personalized, cell-based interceptive medicine for Europe with the potential of improved health outcomes and more cost-effective treatment, resulting in profoundly changing a person’s healthcare experience.

To form a functioning, healthy body, cells follow developmental paths during which they acquire specific roles in tissues and organs. But when they deviate from their healthy course, they accumulate changes leading to disease which remain undetected until symptoms appear. At this point, medical treatment is often invasive, expensive and inefficient. However, now we have the technologies to capture the molecular makeup of individual cells and to detect the emergence of disease or therapy resistance much earlier.

Using breakthrough single-cell and imaging technologies in combination with artificial intelligence and personalized disease models will allow us to not only predict disease onset earlier, but also to select the most effective therapies for individual patients. Targeting disease-causing cells to intercept disorders before irreparable damage occurs will substantially improve the outlook for many patients and has the potential of saving billions of Euros of disease-related costs in Europe.

The perspective article, titled “The LifeTime initiative and the future of cell-based interceptive medicine in Europe,” and the LifeTime Strategic Research Agenda (SRA) explain how these technologies should be rapidly co-developed, transitioned into clinical settings and applied to the five major disease areas. Close interactions between European infrastructures, research institutions, hospitals and industry will be essential to generate, share and analyze LifeTime’s big medical data across European borders. The initiative’s vision advocates ethically responsible research to benefit citizens all across Europe.

According to Professor Nikolaus Rajewsky, scientific director of the Berlin Institute for Medical System Biology at the Max Delbrueck Center for Molecular Medicine and coordinator of the LifeTime Initiative, the LifeTime approach is the way into the future: “LifeTime has brought together scientists across fields—from biologists, to clinicians, data scientists, engineers, mathematicians, and physicists ¬- to enable a much improved understanding of molecular mechanisms driving health and disease. Cell-based medicine will allow doctors to diagnose diseases earlier and intercept disorders before irreparable damage has occurred. LifeTime has a unique value proposition that promises to improve the European patient’s health.

Dr. Geneviève Almouzni, director of research at CNRS, honorary director of the research center from Institut Curie in Paris and co-coordinator of the LifeTime Initiative believes that the future with LifeTime offers major social and economic impact: “By implementing interceptive, cell-based medicine we will be able to considerably improve treatment across many diseases. Patients all over the world will be able to lead longer, healthier lives. The economic impact could be tremendous with billions of Euros saved from productivity gains simply for cancer, and significantly shortened ICU stays for COVID-19. We hope EU leaders will realize we have to invest in the necessary research now.

Thank you for taking your time to send in your valued opinion to Science X editors.

You can be assured our editors closely monitor every feedback sent and will take appropriate actions. Your opinions are important to us.

We do not guarantee individual replies due to extremely high volume of correspondence.

Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient’s address will be used for any other purpose.
The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.

Get weekly and/or daily updates delivered to your inbox.
You can unsubscribe at any time and we’ll never share your details to third parties.

This site uses cookies to assist with navigation, analyse your use of our services, and provide content from third parties.
By using our site, you acknowledge that you have read and understand our Privacy Policy
and Terms of Use.

Source: https://medicalxpress.com/news/2020-09-health-cell-based-interceptive-medicine.html

Medicine, Cell, Health Care, Research

World news – GB – Improving health care through cell-based interceptive medicine

Building on its expertise in the areas of digital, technologies and processes , CSS Engineering you in your most ambitious transformation projects and helps you bring out new ideas, new offers, new modes of collaboration, new ways of producing and selling.

CSS Engineering is involved in projects each customer as if it were his own. We believe a consulting company should be more than an advisor. We put ourselves in the place of our customers, to align we incentives to their goals, and collaborate to unlock the full potential their business. This establishes deep relationships and enjoyable.

Our services:

  1. Create professional websites
  2. Hosting high performance and unlimited
  3. Sale and video surveillance cameras installation
  4. Sale and Installation of security system and alarm
  5. E-Marketing

All our achievements here https://www.css-engineering.com/en/works/

LEAVE A REPLY

Please enter your comment!
Please enter your name here